Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Sponsor: Ludwig-Maximilians - University of Munich
Terminated
Insufficient Recruitment
Other terminated trials from Ludwig-Maximilians - University of Munich
- Bacterial Infections · Phase NA · Nov 2022
- Cerebral Small Vessel Diseases · Phase PHASE3 · Jul 2022
- Sarcoma · Phase PHASE2 · Jul 2016
- Hyperlipoproteinemia · Phase PHASE4 · Jul 2013
- Graft Dysfunction · Phase PHASE2/PHASE3 · Jul 2013
See all terminations from Ludwig-Maximilians - University of Munich
A PHASE2 clinical study on Acute Myeloid Leukemia, Adult, this trial is terminated or withdrawn. The trial is conducted by Ludwig-Maximilians - University of Munich and has accumulated 11 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Feb 2022 — Jul 2024 [monthly]
Terminated PHASE2
-
Oct 2021 — Feb 2022 [monthly]
Terminated PHASE2
-
Apr 2021 — Oct 2021 [monthly]
Terminated PHASE2
▶ Show 6 earlier versions
-
Mar 2021 — Apr 2021 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2019 — May 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ludwig-Maximilians - University of Munich
- University of Jena
For direct contact, visit the study record on ClinicalTrials.gov .